---
category: news
title: "Gilead Sciences Gains Remdesivir Approval in Japan"
excerpt: "Gilead Sciences Inc. (NASDAQ: GILD) took another big step forward in its treatment for COVID-19 on Friday when a Japanese regulatory body approved that treatment. Specifically, the Japanese Ministry of Health,"
publishedDateTime: 2020-05-08T15:32:00Z
webUrl: "https://247wallst.com/healthcare-business/2020/05/08/gilead-sciences-gains-remdesivir-approval-in-japan/"
type: article
quality: 20
heat: 20
published: false

provider:
  name: 24/7 Wall St
  domain: 247wallst.com

topics:
  - Treatment
  - Coronavirus

secured: "9KRcNQ/jsNktu6OaOXX40Mg52tEimWnLgRufAVpjjHmu94uDdHJs+xjGzsGDnuzuu3rDrRKgsEh37wMn86wmBzA1MVjXtoKUN80Xv4mOtyd7jEsfzGrUej+25j+W9ZOy77pLhhfo8K2sLI7Ldmyum3jSkB2TEhDgODeQ2WJtOiHxe717o/eeUW1RJKTCsGeaDk7fph2ShGMEFONBkG2DQ3BfCJVcMGvRGKap71EbzF4e7dRlaVyPuFLoTbfuPDbZJ9hPOqCABkx7sbjY0fW+pbetdUI2Ls7h1NrYQk5PjWJx3sQHEJvmX5qR/oLhkvJt;Ns2GCS/YOx0lw1AkRsABtg=="
---

